Reata Pharmaceuticals, Inc. to Report First Quarter 2019 Financials and to Provide an Update on Development Programs on May 9...
May 02 2019 - 6:45AM
Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage
biopharmaceutical company, today announced that it will report
financial results and provide an update on recent progress on its
development programs on Thursday, May 9th, 2019 at 8:00 a.m. ET
before the market opens.
The conference call will be accessible by
dialing (844)348-3946 (toll-free domestic) or (213)358-0892
(international) using the access code: 5177169. The webcast
link is https://edge.media-server.com/m6/p/cwm9hw5f.
First quarter financial results to be discussed
during the call will be included in an earnings press release that
will be available on the company’s website shortly before the call
at http://news.reatapharma.com and will be available for 12 months
after the call. The audio recording and webcast will be
accessible for at least 90 days after the event through the
Investors section of the company’s website at
http://reatapharma.com.
About Reata Pharmaceuticals,
Inc.
Reata is a clinical-stage biopharmaceutical
company that develops novel therapeutics for patients with serious
or life-threatening diseases by targeting molecular pathways
involved in the regulation of cellular metabolism and inflammation.
Reata’s two most advanced clinical candidates, bardoxolone
methyl (bardoxolone) and omaveloxolone, target the important
transcription factor Nrf2 that promotes the resolution of
inflammation by restoring mitochondrial function, reducing
oxidative stress, and inhibiting pro-inflammatory signaling.
Bardoxolone and omaveloxolone are investigational medicines, and
their safety and efficacy have not been established by any
agency.
Contact:Reata Pharmaceuticals, Inc.(972)
865-2219http://reatapharma.com
Investors:Vinny JindalVice President,
Strategy(469)
374-8721ir@reatapharma.comhttps://reatapharma.com/contact-us/
Media:Matt Middleman, M.D.LifeSci Public
Relations(646)
627-8384matt.middleman@lifescipublicrelations.com
Reata Pharmaceuticals (NASDAQ:RETA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Reata Pharmaceuticals (NASDAQ:RETA)
Historical Stock Chart
From Apr 2023 to Apr 2024